PLASMA-CELL PROLIFERATION IN MONOCLONAL GAMMOPATHY - RELATIONS WITH OTHER BIOLOGIC VARIABLES - DIAGNOSTIC AND PROGNOSTIC-SIGNIFICANCE

被引:10
作者
FFRENCH, M
FFRENCH, P
REMY, F
CHAPUISCELLIER, C
WOLOWIEC, D
VILLE, D
BRYON, PA
机构
[1] HOP EDOUARD HERRIOT,CENT HEMATOL & CYTOGENET LAB,LYON,FRANCE
[2] HOP EDOUARD HERRIOT,BIOCHIM LAB,LYON,FRANCE
关键词
D O I
10.1016/S0002-9343(99)80081-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: We investigated the place of direct plasma cell proliferation analysis beside other biologic data in monoclonal gammopathy, particularly the serum level of C-reactive protein (C-RP) PATIENTS: Eighty patients were studied at the time of their diagnosis. Patients with a serum creatinine level greater than 200 mu mol/L were excluded. METHODS: Plasma cell proliferation analysis was performed after bromodeoxyuridine incorporation and double immunoenzymatic labeling on cytological smears, making determination of the plasma cell labeling index (LI) possible. The other biologic variables studied were related to tumor burden (plasmacytosis, hemoglobin, serum levels of monoclonal immunoglobulin, albumin) or to kidney function (creatinine). beta(2)-microglobulin (beta 2-M), C-RP, lactic dehydrogenase (LDH), and calcemia were also assessed. RESULTS: No correlation was found between LI and serum C-RP. LDH was the sole variable significantly correlated to C-RP (P <0.01). Besides the biologic parameters used for the staging according to the Durie and Salmon classification, beta(2)-M, albumin and LI were significantly different between stages (P <0.0002, <0.0004, <0.00001). LDH and C-RP showed no significant difference. Results were similar when patients with and without bone lesions were analyzed separately. Multivariate analysis ranked these variables as follows with respect to prognostic value: beta(2)-M, LI, and age. CONCLUSION: Among the variables analyzed, LI is the sole true reflector of cell proliferation. We confirm its diagnostic and prognostic value.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 24 条
[1]   BONE-MARROW HISTOLOGY IN MYELOMA - ITS IMPORTANCE IN DIAGNOSIS, PROGNOSIS, CLASSIFICATION AND STAGING [J].
BARTL, R ;
FRISCH, B ;
BURKHARDT, R ;
FATEHMOGHADAM, A ;
MAHL, G ;
GIERSTER, P ;
SUND, M ;
KETTNER, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (03) :361-375
[2]  
BATAILLE R, 1984, BLOOD, V63, P468
[3]  
BATAILLE R, 1992, BLOOD, V80, P733
[4]   SERUM LEVELS OF INTERLEUKIN-6, A POTENT MYELOMA CELL-GROWTH FACTOR, AS A REFLECT OF DISEASE SEVERITY IN PLASMA-CELL DYSCRASIAS [J].
BATAILLE, R ;
JOURDAN, M ;
ZHANG, XG ;
KLEIN, B .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :2008-2011
[5]   PROGNOSTIC FACTORS AND STAGING IN MULTIPLE-MYELOMA - A REAPPRAISAL [J].
BATAILLE, R ;
DURIE, BGM ;
GRENIER, J ;
SANY, J .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (01) :80-87
[6]   LACK OF CORRELATION BETWEEN PLASMA-CELL THYMIDINE LABELING INDEX AND SERUM BETA-2-MICROGLOBULIN IN MONOCLONAL GAMMOPATHIES [J].
BOCCADORO, M ;
DURIE, BGM ;
FRUTIGER, Y ;
GAVAROTTI, P ;
REDOGLIA, V ;
MASSAIA, M ;
DALBERTO, M ;
MARMONT, F ;
GALLAMINI, A ;
TRIBALTO, M ;
PILERI, A .
ACTA HAEMATOLOGICA, 1987, 78 (04) :239-242
[7]   LOW PLASMA-CELL 3(H) THYMIDINE INCORPORATION IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS), SMOULDERING MYELOMA AND REMISSION PHASE MYELOMA - A RELIABLE INDICATOR OF PATIENTS NOT REQUIRING THERAPY [J].
BOCCADORO, M ;
GAVAROTTI, P ;
FOSSATI, G ;
PILERI, A ;
MARMONT, F ;
NERETTO, G ;
GALLAMINI, A ;
VOLTA, C ;
TRIBALTO, M ;
TESTA, MG ;
AMADORI, S ;
MANDELLI, F ;
DURIE, BGM .
BRITISH JOURNAL OF HAEMATOLOGY, 1984, 58 (04) :689-696
[8]  
CHERNG NC, 1991, CANCER, V67, P3150, DOI 10.1002/1097-0142(19910615)67:12<3150::AID-CNCR2820671236>3.0.CO
[9]  
2-U
[10]  
DURIE BGM, 1980, BLOOD, V55, P364